Drugs / Bifid Triple Viable Capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02929225 | Dec 2016 → Jan 2018 | end stage renal failure | First Affiliated Hospital Xi'an Jiaotong University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifid Triple Viable Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02929225 ↗ |
| Modality | Other / unclassified | “A biological preparation composed of triple viable microbe” NCT02929225 ↗ |